Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

ACM Research (Shanghai) Plans RMB 299M Dividend

ACM Research (Shanghai) reported that it plans to distribute a cash dividend of RMB 6.233 per 10 shares for fiscal 2025, equal to a total payout of RMB 299.0 million. The company said the plan is based on 480.2 million shares outstanding as of Dec. 31, 2025, minus 443,400 shares held in its repurchase account.

The proposed dividend is higher than the RMB 288.3 million cash dividend for fiscal 2024 and the RMB 273.2 million paid for fiscal 2023. Over the three most recent fiscal years, ACM Shanghai has paid RMB 860.5 million in cash dividends, with no repurchase-and-cancellation amount recorded.

Net profit attributable to shareholders of the listed company rose to RMB 1.396 billion in 2025 from RMB 1.153 billion in 2024, an increase of 21.05%. The company’s proposed cash dividend, combined with shares repurchased during the year for RMB 50.0 million, came to RMB 349.0 million, equal to 25.00% of 2025 net profit.

ACM Shanghai’s undistributed profit at year-end reached RMB 3.34 billion, compared with the RMB 288.3 million cash dividend paid in 2024 and the RMB 2.481 billion in beginning undistributed profit carried into 2025. After deducting the statutory surplus reserve of RMB 20.7 million, the company said distributable profit stood at RMB 3.34 billion at the end of 2025.

Research spending over the three most recent fiscal years totaled RMB 2.752 billion, while revenue over the same period totaled RMB 16.292 billion, putting R&D at 16.89% of revenue. As a result of these announcements, the company's shares have moved 2.73% on the market, and are now trading at a price of $53.62. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS